HSK44459

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for HSK44459, covering 2025-03-05 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis [Phase 2]